Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate CancerThanakorn Pungsrinont(Jena University Hospital), Aria Baniahmad(Jena University Hospital)International Journal of Molecular SciencesOctober 14, 202110.3390/ijms222011088Cited by 203SaveCiteExport RISWatch citationsRelated PapersSupraphysiological androgen levels induce cellular senescence in human prostate cancer cells through the Src-Akt pathway|Molecular Cancer|2014|87